297 related articles for article (PubMed ID: 20185819)
1. TRAF3 controls activation of the canonical and alternative NFkappaB by the lymphotoxin beta receptor.
Bista P; Zeng W; Ryan S; Bailly V; Browning JL; Lukashev ME
J Biol Chem; 2010 Apr; 285(17):12971-8. PubMed ID: 20185819
[TBL] [Abstract][Full Text] [Related]
2. The NF-κB subunit RelB controls p100 processing by competing with the kinases NIK and IKK1 for binding to p100.
Fusco AJ; Mazumder A; Wang VY; Tao Z; Ware C; Ghosh G
Sci Signal; 2016 Sep; 9(447):ra96. PubMed ID: 27678221
[TBL] [Abstract][Full Text] [Related]
3. Induction of the alternative NF-κB pathway by lymphotoxin αβ (LTαβ) relies on internalization of LTβ receptor.
Ganeff C; Remouchamps C; Boutaffala L; Benezech C; Galopin G; Vandepaer S; Bouillenne F; Ormenese S; Chariot A; Schneider P; Caamaño J; Piette J; Dejardin E
Mol Cell Biol; 2011 Nov; 31(21):4319-34. PubMed ID: 21896778
[TBL] [Abstract][Full Text] [Related]
4. A TNF-p100 pathway subverts noncanonical NF-κB signaling in inflamed secondary lymphoid organs.
Mukherjee T; Chatterjee B; Dhar A; Bais SS; Chawla M; Roy P; George A; Bal V; Rath S; Basak S
EMBO J; 2017 Dec; 36(23):3501-3516. PubMed ID: 29061763
[TBL] [Abstract][Full Text] [Related]
5. Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma.
Keats JJ; Fonseca R; Chesi M; Schop R; Baker A; Chng WJ; Van Wier S; Tiedemann R; Shi CX; Sebag M; Braggio E; Henry T; Zhu YX; Fogle H; Price-Troska T; Ahmann G; Mancini C; Brents LA; Kumar S; Greipp P; Dispenzieri A; Bryant B; Mulligan G; Bruhn L; Barrett M; Valdez R; Trent J; Stewart AK; Carpten J; Bergsagel PL
Cancer Cell; 2007 Aug; 12(2):131-44. PubMed ID: 17692805
[TBL] [Abstract][Full Text] [Related]
6. Negative feedback in noncanonical NF-kappaB signaling modulates NIK stability through IKKalpha-mediated phosphorylation.
Razani B; Zarnegar B; Ytterberg AJ; Shiba T; Dempsey PW; Ware CF; Loo JA; Cheng G
Sci Signal; 2010 May; 3(123):ra41. PubMed ID: 20501937
[TBL] [Abstract][Full Text] [Related]
7. Zinc-finger protein 91 plays a key role in LIGHT-induced activation of non-canonical NF-κB pathway.
Jin HR; Jin X; Lee JJ
Biochem Biophys Res Commun; 2010 Oct; 400(4):581-6. PubMed ID: 20804734
[TBL] [Abstract][Full Text] [Related]
8. MKK4 activates non-canonical NFκB signaling by promoting NFκB2-p100 processing.
Kim JS; Kim EJ; Kim HS; Kurie JM; Ahn YH
Biochem Biophys Res Commun; 2017 Sep; 491(2):337-342. PubMed ID: 28733031
[TBL] [Abstract][Full Text] [Related]
9. Specificity of TRAF3 in its negative regulation of the noncanonical NF-kappa B pathway.
He JQ; Saha SK; Kang JR; Zarnegar B; Cheng G
J Biol Chem; 2007 Feb; 282(6):3688-94. PubMed ID: 17158868
[TBL] [Abstract][Full Text] [Related]
10. Roles of TRAF2 and TRAF3 in Epstein-Barr virus latent membrane protein 1-induced alternative NF-kappaB activation.
Song YJ; Kang MS
Virus Genes; 2010 Oct; 41(2):174-80. PubMed ID: 20585848
[TBL] [Abstract][Full Text] [Related]
11. XEDAR activates the non-canonical NF-κB pathway.
Verhelst K; Gardam S; Borghi A; Kreike M; Carpentier I; Beyaert R
Biochem Biophys Res Commun; 2015 Sep; 465(2):275-80. PubMed ID: 26260321
[TBL] [Abstract][Full Text] [Related]
12. A roadmap of constitutive NF-κB activity in Hodgkin lymphoma: Dominant roles of p50 and p52 revealed by genome-wide analyses.
de Oliveira KA; Kaergel E; Heinig M; Fontaine JF; Patone G; Muro EM; Mathas S; Hummel M; Andrade-Navarro MA; Hübner N; Scheidereit C
Genome Med; 2016 Mar; 8(1):28. PubMed ID: 26988706
[TBL] [Abstract][Full Text] [Related]
13. Allosteric regulation of the ubiquitin:NIK and ubiquitin:TRAF3 E3 ligases by the lymphotoxin-beta receptor.
Sanjo H; Zajonc DM; Braden R; Norris PS; Ware CF
J Biol Chem; 2010 May; 285(22):17148-55. PubMed ID: 20348096
[TBL] [Abstract][Full Text] [Related]
14. Maximal adamantyl-substituted retinoid-related molecule-induced apoptosis requires NF-κB noncanonical and canonical pathway activation.
Farhana L; Dawson MI; Murshed F; Fontana JA
Cell Death Differ; 2011 Jan; 18(1):164-73. PubMed ID: 20671747
[TBL] [Abstract][Full Text] [Related]
15. Lymphotoxin beta receptor induces sequential activation of distinct NF-kappa B factors via separate signaling pathways.
Müller JR; Siebenlist U
J Biol Chem; 2003 Apr; 278(14):12006-12. PubMed ID: 12556537
[TBL] [Abstract][Full Text] [Related]
16. Lymphotoxin-β receptor-NIK signaling induces alternative RELB/NF-κB2 activation to promote metastatic gene expression and cell migration in head and neck cancer.
Das R; Coupar J; Clavijo PE; Saleh A; Cheng TF; Yang X; Chen J; Van Waes C; Chen Z
Mol Carcinog; 2019 Mar; 58(3):411-425. PubMed ID: 30488488
[TBL] [Abstract][Full Text] [Related]
17. NFκB-inducing kinase inhibits NFκB activity specifically in neurons of the CNS.
Mao X; Phanavanh B; Hamdan H; Moerman-Herzog AM; Barger SW
J Neurochem; 2016 Apr; 137(2):154-63. PubMed ID: 26778773
[TBL] [Abstract][Full Text] [Related]
18. Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-kappaB signaling.
Vallabhapurapu S; Matsuzawa A; Zhang W; Tseng PH; Keats JJ; Wang H; Vignali DA; Bergsagel PL; Karin M
Nat Immunol; 2008 Dec; 9(12):1364-70. PubMed ID: 18997792
[TBL] [Abstract][Full Text] [Related]
19. Catalytic subunits of the phosphatase calcineurin interact with NF-κB-inducing kinase (NIK) and attenuate NIK-dependent gene expression.
Shinzawa M; Konno H; Qin J; Akiyama N; Miyauchi M; Ohashi H; Miyamoto-Sato E; Yanagawa H; Akiyama T; Inoue J
Sci Rep; 2015 Jun; 5():10758. PubMed ID: 26029823
[TBL] [Abstract][Full Text] [Related]
20. Constitutive BR3 receptor signaling in diffuse, large B-cell lymphomas stabilizes nuclear factor-κB-inducing kinase while activating both canonical and alternative nuclear factor-κB pathways.
Pham LV; Fu L; Tamayo AT; Bueso-Ramos C; Drakos E; Vega F; Medeiros LJ; Ford RJ
Blood; 2011 Jan; 117(1):200-10. PubMed ID: 20889926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
